{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:45:36Z","timestamp":1792442736432,"version":"4.5.0"},"reference-count":52,"publisher":"BMJ","issue":"5","funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2018,11,30]]},"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>We assessed the decision-making of individuals pursuing genomic sequencing without a requirement for pretest genetic counselling. We sought to describe the extent to which individuals who decline genetic counselling reported decisional conflict or struggled to make a decision to pursue genomic testing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We administered a 100-item survey to 3037 individuals who consented to the Return of Actionable Variants Empirical study, a genomic medicine implementation study supported by the National Institutes of Health (USA) eMERGE consortium. The primary outcomes of interest were self-reported decisional conflict about the decision to participate in the study and time required to reach a decision.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We received 2895 completed surveys (response rate=95.3%), and of these respondents 97.8% completed the decisional conflict scale in its entirety. A majority of individuals (63%) had minimal or no decisional conflict about the pursuit of genomic sequencing and were able to reach a decision quickly (78%). Multivariable logistic regression analyses identified several characteristics associated with decisional conflict, including lower education, lower health literacy, lower self-efficacy in coping, lack of prior experience with genetic testing, not discussing study participation with a family member or friend, and being male.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>As genomic sequencing is used more widely, genetic counselling resources may not be sufficient to meet demand. Our results challenge the notion that all individuals need genetic counselling in order to make an informed decision about genomic sequencing.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jmedgenet-2018-105577","type":"journal-article","created":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T17:15:16Z","timestamp":1545498916000},"page":"317-324","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["Should pretest genetic counselling be required for patients pursuing genomic sequencing? Results from a survey of participants in a large genomic implementation study"],"prefix":"10.1136","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3103-7805","authenticated-orcid":false,"given":"Joel E","family":"Pacyna","sequence":"first","affiliation":[{"name":"Biomedical Ethics Research Program, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Radecki Breitkopf","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Division of Biostatistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica J","family":"Sutton","sequence":"additional","affiliation":[{"name":"Biomedical Ethics Research Program, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Horrow","sequence":"additional","affiliation":[{"name":"Biomedical Ethics Research Program, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iftikhar J","family":"Kullo","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5441-2084","authenticated-orcid":false,"given":"Richard R","family":"Sharp","sequence":"additional","affiliation":[{"name":"Biomedical Ethics Research Program, Mayo Clinic, Rochester, Minnesota, USA"},{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,12,22]]},"reference":[{"key":"2025100521052549000_56.5.317.1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.0827002"},{"key":"2025100521052549000_56.5.317.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31825b07f8"},{"key":"2025100521052549000_56.5.317.3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.0996"},{"key":"2025100521052549000_56.5.317.4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s10897-018-0230-z","article-title":"Operationalizing the Reciprocal Engagement Model of Genetic Counseling Practice: a Framework for the Scalable Delivery of Genomic Counseling and Testing","volume":"27","author":"Schmidlen","year":"2018","journal-title":"J Genet Couns"},{"key":"2025100521052549000_56.5.317.5","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-015-9836-6"},{"key":"2025100521052549000_56.5.317.6","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/gim.2017.240","article-title":"Making pretest genomic counseling optional: lessons from the RAVE study","volume":"20","author":"Sutton","year":"2018","journal-title":"Genet Med"},{"key":"2025100521052549000_56.5.317.7","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.mayocp.2018.06.026","article-title":"The Return of Actionable Variants Empirical (RAVE) Study, a Mayo Clinic genomic medicine implementation study: design and initial results","volume":"93","author":"Kullo","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"2025100521052549000_56.5.317.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2013.06.006"},{"key":"2025100521052549000_56.5.317.9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5339\/gcsp.2013.10","article-title":"An electronic medical record-linked biorepository to identify novel biomarkers for atherosclerotic cardiovascular disease","volume":"2013","author":"Ye","year":"2013","journal-title":"Glob Cardiol Sci Pract"},{"key":"2025100521052549000_56.5.317.10","unstructured":"Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Questionnaire (BRFSS). 2014. https:\/\/www.cdc.gov\/brfss\/questionnaires\/pdf-ques\/2014_BRFSS.pdf"},{"key":"2025100521052549000_56.5.317.11","doi-asserted-by":"publisher","DOI":"10.1177\/109019817800600107"},{"key":"2025100521052549000_56.5.317.12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1399-0004.2012.01909.x","article-title":"Effects of informed consent for individual genome sequencing on relevant knowledge","volume":"82","author":"Kaphingst","year":"2012","journal-title":"Clin Genet"},{"key":"2025100521052549000_56.5.317.13","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-008-0520-5"},{"key":"2025100521052549000_56.5.317.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2005.00404.x"},{"key":"2025100521052549000_56.5.317.15","doi-asserted-by":"publisher","DOI":"10.1093\/geronb\/63.6.S369"},{"key":"2025100521052549000_56.5.317.16","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9501500105"},{"key":"2025100521052549000_56.5.317.17","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0004.2002.610205.x"},{"key":"2025100521052549000_56.5.317.18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1525\/jer.2008.3.3.69","article-title":"Decisional conflict among patients who accept or decline participation in phase I oncology studies","volume":"3","author":"Flynn","year":"2008","journal-title":"J Empir Res Hum Res Ethics"},{"key":"2025100521052549000_56.5.317.19","unstructured":"O\u2019Connor AM . User Manual - Decisional Conflict Scale. 1993. https:\/\/decisionaid.ohri.ca\/docs\/develop\/User_Manuals\/UM_decisional_conflict.pdf"},{"key":"2025100521052549000_56.5.317.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2007.07.030"},{"key":"2025100521052549000_56.5.317.21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1037\/0278-6133.27.6.711","article-title":"Influence of a patient decision aid on decisional conflict related to PSA testing: a structural equation model","volume":"27","author":"Stephens","year":"2008","journal-title":"Health Psychol"},{"key":"2025100521052549000_56.5.317.22","doi-asserted-by":"publisher","DOI":"10.1177\/1557988308325460"},{"key":"2025100521052549000_56.5.317.23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pec.2012.12.013","article-title":"Fostering informed decisions: a randomized controlled trial assessing the impact of a decision aid among men registered to undergo mass screening for prostate cancer","volume":"91","author":"Williams","year":"2013","journal-title":"Patient Educ Couns"},{"key":"2025100521052549000_56.5.317.24","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1353\/hpu.2014.0148","article-title":"Affecting African American men\u2019s prostate cancer screening decision-making through a mobile tablet-mediated intervention","volume":"25","author":"Sultan","year":"2014","journal-title":"J Health Care Poor Underserved"},{"key":"2025100521052549000_56.5.317.25","doi-asserted-by":"publisher","DOI":"10.1037\/a0034405"},{"key":"2025100521052549000_56.5.317.26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/cncr.30367","article-title":"Informed decision making before prostate-specific antigen screening: Initial results using the American Cancer Society (ACS) Decision Aid (DA) among medically underserved men","volume":"123","author":"G\u00f6kce","year":"2017","journal-title":"Cancer"},{"key":"2025100521052549000_56.5.317.27","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.19.2039"},{"key":"2025100521052549000_56.5.317.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-7625.2008.00514.x"},{"key":"2025100521052549000_56.5.317.29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/jamainternmed.2013.13639","article-title":"Development and evaluation of a decision aid on mammography screening for women 75 years and older","volume":"174","author":"Schonberg","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2025100521052549000_56.5.317.30","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1089\/jwh.2015.5256","article-title":"Mammography decision aid reduces decisional conflict for women in their forties considering screening","volume":"24","author":"Eden","year":"2015","journal-title":"J Womens Health"},{"key":"2025100521052549000_56.5.317.31","doi-asserted-by":"crossref","unstructured":"Scariati P , Nelson L , Watson L , Bedrick S , Eden KB . Impact of a decision aid on reducing uncertainty: pilot study of women in their 40s and screening mammography Clinical decision-making, knowledge support systems, and theory. BMC medical informatics and decision making 2015;15.","DOI":"10.1186\/s12911-015-0210-2"},{"key":"2025100521052549000_56.5.317.32","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1186\/s12889-017-4889-0","article-title":"Impact of a decision aid about stratified ovarian cancer risk-management on women\u2019s knowledge and intentions: a randomised online experimental survey study","volume":"17","author":"Meisel","year":"2017","journal-title":"BMC Public Health"},{"key":"2025100521052549000_56.5.317.33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/1354850031000135713","article-title":"What is the significance of attendance by the partner at genetic counselling for advanced maternal age?","volume":"8","author":"Humphreys","year":"2003","journal-title":"Psychol Health Med"},{"key":"2025100521052549000_56.5.317.34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0738-3991(03)00190-3","article-title":"Psychological responses to prenatal NTS counseling and the uptake of invasive testing in women of advanced maternal age","volume":"54","author":"Kaiser","year":"2004","journal-title":"Patient Educ Couns"},{"key":"2025100521052549000_56.5.317.35","doi-asserted-by":"publisher","DOI":"10.1097\/01.GIM.0000162876.65555.AB"},{"key":"2025100521052549000_56.5.317.36","doi-asserted-by":"publisher","DOI":"10.1002\/pon.1352"},{"key":"2025100521052549000_56.5.317.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2009.09.036"},{"key":"2025100521052549000_56.5.317.38","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1188\/11.ONF.572-581","article-title":"Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not","volume":"38","author":"Katapodi","year":"2011","journal-title":"Oncol Nurs Forum"},{"key":"2025100521052549000_56.5.317.39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/1471-2407-12-320","article-title":"How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer","volume":"12","author":"Watts","year":"2012","journal-title":"BMC Cancer"},{"key":"2025100521052549000_56.5.317.40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/gm518","article-title":"Informed decision-making among students analyzing their personal genomes on a whole genome sequencing course: a longitudinal cohort study","volume":"5","author":"Sanderson","year":"2013","journal-title":"Genome Med"},{"key":"2025100521052549000_56.5.317.41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10689-013-9644-9","article-title":"Can we test for hereditary cancer at 18 years when we start surveillance at 25? Patient reported outcomes","volume":"12","author":"Sie","year":"2013","journal-title":"Fam Cancer"},{"key":"2025100521052549000_56.5.317.42","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.1188\/14.CJON.E58-E63","article-title":"Decision making after BRCA genetic testing","volume":"18","author":"Connors","year":"2014","journal-title":"Clinical journal of oncology nursing"},{"key":"2025100521052549000_56.5.317.43","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.11479"},{"key":"2025100521052549000_56.5.317.44","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.9557"},{"key":"2025100521052549000_56.5.317.45","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/hex.12363","article-title":"It\u2019s complicated - Factors predicting decisional conflict in prenatal diagnostic testing","volume":"19","author":"Muller","year":"2016","journal-title":"Health Expect"},{"key":"2025100521052549000_56.5.317.46","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/pd.5149","article-title":"Group genetic counseling: an alternate service delivery model in a high risk prenatal screening population","volume":"37","author":"Cloutier","year":"2017","journal-title":"Prenat Diagn"},{"key":"2025100521052549000_56.5.317.47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.urology.2017.02.052","article-title":"Use of a 17-gene prognostic assay in contemporary urologic practice: results of an interim analysis in an observational cohort","volume":"107","author":"Eure","year":"2017","journal-title":"Urology"},{"key":"2025100521052549000_56.5.317.48","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s10897-016-9935-z","article-title":"Impact of genomic counseling on informed decision-making among ostensibly healthy individuals seeking personal genome sequencing: the healthseq project","volume":"25","author":"Suckiel","year":"2016","journal-title":"J Genet Couns"},{"key":"2025100521052549000_56.5.317.49","doi-asserted-by":"publisher","DOI":"10.1080\/01443610220130508"},{"key":"2025100521052549000_56.5.317.50","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s10897-018-0254-4","article-title":"Involvement and influence of healthcare providers, family members, and other mutation carriers in the cancer risk management decision-making process of BRCA1 and BRCA2 Mutation Carriers","volume":"27","author":"Puski","year":"2018","journal-title":"J Genet Couns"},{"key":"2025100521052549000_56.5.317.51","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X13491463"},{"key":"2025100521052549000_56.5.317.52","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28879"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmedgenet-2018-105577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T04:05:36Z","timestamp":1759723536000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmedgenet-2018-105577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,22]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,4,25]]},"published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1136\/jmedgenet-2018-105577"],"URL":"https:\/\/doi.org\/10.1136\/jmedgenet-2018-105577","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,22]]}}}